These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Rawstron AC; Orfao A; Beksac M; Bezdickova L; Brooimans RA; Bumbea H; Dalva K; Fuhler G; Gratama J; Hose D; Kovarova L; Lioznov M; Mateo G; Morilla R; Mylin AK; Omedé P; Pellat-Deceunynck C; Perez Andres M; Petrucci M; Ruggeri M; Rymkiewicz G; Schmitz A; Schreder M; Seynaeve C; Spacek M; de Tute RM; Van Valckenborgh E; Weston-Bell N; Owen RG; San Miguel JF; Sonneveld P; Johnsen HE; Haematologica; 2008 Mar; 93(3):431-8. PubMed ID: 18268286 [TBL] [Abstract][Full Text] [Related]
5. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Lin P; Owens R; Tricot G; Wilson CS Am J Clin Pathol; 2004 Apr; 121(4):482-8. PubMed ID: 15080299 [TBL] [Abstract][Full Text] [Related]
6. Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma. Bae MH; Park CJ; Kim BH; Cho YU; Jang S; Lee DH; Seo EJ; Yoon DH; Lee JH; Suh C Cytometry B Clin Cytom; 2018 May; 94(3):493-499. PubMed ID: 29220877 [TBL] [Abstract][Full Text] [Related]
8. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients. Kara IO; Sahin B; Paydas S; Cetiner S Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184 [TBL] [Abstract][Full Text] [Related]
9. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance. Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187 [TBL] [Abstract][Full Text] [Related]
10. [Detection of multiple myeloma cells using multicolor immunofluorescence and flow cytometry]. Tousková M; Maisnar V; Krejsek J; Kopecký O Vnitr Lek; 1999 Dec; 45(12):708-12. PubMed ID: 10951845 [TBL] [Abstract][Full Text] [Related]
11. Methodological considerations for the high sensitivity detection of multiple myeloma measurable residual disease. Soh KT; Tario JD; Hahn TE; Hillengass J; McCarthy PL; Wallace PK Cytometry B Clin Cytom; 2020 Mar; 98(2):161-173. PubMed ID: 31868315 [TBL] [Abstract][Full Text] [Related]
12. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma. Flores-Montero J; de Tute R; Paiva B; Perez JJ; Böttcher S; Wind H; Sanoja L; Puig N; Lecrevisse Q; Vidriales MB; van Dongen JJ; Orfao A Cytometry B Clin Cytom; 2016 Jan; 90(1):61-72. PubMed ID: 26100534 [TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma. Liu D; Lin P; Hu Y; Zhou Y; Tang G; Powers L; Medeiros LJ; Jorgensen JL; Wang SA J Clin Pathol; 2012 Sep; 65(9):823-9. PubMed ID: 22685235 [TBL] [Abstract][Full Text] [Related]
15. Expression of CD52 on plasma cells in plasma cell proliferative disorders. Kumar S; Kimlinger TK; Lust JA; Donovan K; Witzig TE Blood; 2003 Aug; 102(3):1075-7. PubMed ID: 12714489 [TBL] [Abstract][Full Text] [Related]
16. [Utility of 8-colours multiparameter flow cytometry immunophenotyping of plasma cells for the management of monoclonal gammopathy]. Gressier M; Chaquin M; Lhermitte L; Asnafi V; Macintyre E; Brouzes C Ann Biol Clin (Paris); 2013; 71(3):313-23. PubMed ID: 23747669 [TBL] [Abstract][Full Text] [Related]
17. [The immunological phenotype and proliferative activity of the tumor lymphocytes in multiple myeloma]. Golenkov AK; Nazarova IN; Sarycheva TG; Miterev GIu; Kozinets GI Ter Arkh; 1993; 65(7):38-41. PubMed ID: 8211777 [TBL] [Abstract][Full Text] [Related]
18. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells. Kim D; Park CY; Medeiros BC; Weissman IL Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078 [TBL] [Abstract][Full Text] [Related]
19. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Pojero F; Flores-Montero J; Sanoja L; Pérez JJ; Puig N; Paiva B; Bottcher S; van Dongen JJ; Orfao A; Cytometry B Clin Cytom; 2016 Jan; 90(1):91-100. PubMed ID: 26130131 [TBL] [Abstract][Full Text] [Related]
20. Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry. Conway EJ; Wen J; Feng Y; Mo A; Huang WT; Keever-Taylor CA; Hari P; Vesole DH; Chang CC Arch Pathol Lab Med; 2009 Oct; 133(10):1594-9. PubMed ID: 19792049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]